In an adult with extensive or refractory tinea (ringworm), which oral antifungal medication is recommended?

Oral Antifungal Treatment for Ringworm

For adults with extensive or refractory ringworm (tinea corporis/cruris), terbinafine 250 mg daily for 1-2 weeks is the recommended first-line oral therapy, offering superior efficacy against the most common causative organisms (Trichophyton species) with shorter treatment duration than alternatives.

First-Line Oral Agents

The choice between oral antifungals depends on the causative organism and infection site:

Terbinafine (Preferred for Most Cases)

• Dosing: 250 mg daily for 1-2 weeks for tinea corporis/cruris 1, 2
• Best for: Trichophyton species (T. tonsurans, T. violaceum, T. soudanense) - the most common pathogens 3
• Advantages: Shorter treatment course (improves compliance), highly effective, well-tolerated, inexpensive 4
• Studies demonstrate complete clinical and mycological cure with just 1 week of therapy 1

Griseofulvin (Alternative)

• Dosing: 1 g daily for adults >50 kg for 6-8 weeks 3
• Best for: Microsporum species (M. canis, M. audouinii) 3
• Disadvantages: Much longer treatment duration (6-8 weeks vs 1-2 weeks), lower compliance

Second-Line Options

Itraconazole

• Dosing: 100-200 mg daily for 1-2 weeks 2
• Indication: Treatment failure with first-line agents, or when organism sensitivity is uncertain 3
• Advantage: Effective against both Trichophyton and Microsporum species 3
• Can use pulse dosing: 200 mg daily for 7 days 2

Fluconazole

• Dosing: 50-100 mg daily for 2-3 weeks, or 150 mg once weekly for 2-3 weeks 2
• Indication: Refractory cases or when other agents contraindicated 3

Clinical Decision Algorithm

1. Start empirically with terbinafine 250 mg daily for 1-2 weeks - covers >90% of cases (Trichophyton predominant) 4

2. If culture identifies Microsporum species: Switch to griseofulvin 1 g daily for 6-8 weeks 3

3. If treatment failure after 2-4 weeks:

   • First assess compliance, drug absorption, and reinfection 3
   • Switch to itraconazole 100-200 mg daily for 2-4 weeks 3

4. For extensive disease or immunocompromised patients: Consider combination of oral therapy with topical antifungals 5, 4

Important Caveats

Diagnostic confirmation is underutilized but critical: Only 20% of providers routinely test for tinea, leading to misdiagnosis and inappropriate treatment 6. Consider KOH prep or fungal culture, especially with:

• Atypical presentations
• Treatment failures
• Suspected drug-resistant cases (emerging concern) 4, 6

Avoid combination antifungal-corticosteroid products: These can worsen infection and contribute to emerging drug resistance 4

Treatment endpoint is mycological cure, not just clinical improvement: Consider repeat testing to confirm eradication, particularly in extensive or refractory cases 3

Drug interactions with itraconazole: Enhanced toxicity with warfarin, certain antihistamines, statins, and many other medications - review carefully before prescribing 3